Zazove Associates’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Sell
100,000
-200,000
-67% -$255K 0.01% 128
2026
Q1
$360K Buy
300,000
+150,000
+100% +$185K 0.02% 139
2025
Q4
$189K Sell
150,000
-57,600
-28% -$80.2K 0.02% 130
2025
Q3
$322K Hold
207,600
0.03% 115
2025
Q2
$274K Hold
207,600
0.02% 112
2025
Q1
$345K Buy
207,600
+202,700
+4,137% +$334K 0.03% 105
2024
Q4
$7.2K Buy
+4,900
New +$7.49K ﹤0.01% 130

Other funds holding OPK

Zazove Associates's OPK Position: Q2 2026 in Review

Zazove Associates reduced its Opko Health (OPK) stake by 67% in Q2 2026, selling an estimated $255K and leaving 100,000 shares worth $150K. The position accounts for 0.01% of the portfolio, ranked #128.

Zazove Associates first reported a position in OPK in Q4 2024 and has held it in 7 quarters since. The position peaked at $360K in Q1 2026. 39 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Zazove Associates held 100,000 shares of Opko Health worth $150K as of Q2 2026.
  • Zazove Associates sold 200,000 Opko Health shares in Q2 2026, an estimated $255K.
  • Opko Health made up 0.01% of Zazove Associates's portfolio in Q2 2026, its #128 holding.
  • Zazove Associates first reported a position in Opko Health in Q4 2024 and has held it in 7 quarters since.
  • Zazove Associates's Opko Health position peaked at $360K in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Zazove Associates's 13F filing for Q2 2026, filed 16 Jul 2026.